(Q73526403)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230157%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Effect of aspirin dosage and enteric coating on platelet reactivity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230157%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

4

M A Mittleman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230157%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

8

G H Tofler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230157%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

7

J E Muller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230157%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

6

I Lipinska

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230157%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

D Feng

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230157%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C McKenna

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230157%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J Murillo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230157%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

O C Gebara

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230157%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 July 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230157%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230157%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230157%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230157%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

189-193

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230157%20AND%20SRC:MED&resulttype=core&format=json

Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Final report on the aspirin component of the ongoing Physicians' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Aspirin in the prevention of myocardial infarction. Current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

A regimen for low-dose aspirin?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Differential inhibition of prostacyclin production and platelet aggregation by aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Aspirin therapy: optimized platelet inhibition with different loading and maintenance doses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Effects of aspirin on platelet aggregation as a function of dosage and time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Regulatory functions of the vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Absorption kinetics of aspirin in man following oral administration of an aqueous solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

In vivo measurement of thromboxane B2 and 6-keto-prostaglandin F1 alpha in humans in response to a standardized vascular injury and the influence of aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Aspirin wars: the optimal dose of aspirin prevent stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Acetylsalicylic acid 100 mg and 1000 mg daily in acute myocardial infarction suspects: a placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

Two year Cottbus reinfarction study with 30 mg aspirin per day

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900316-0

10.1016/S0002-9149(97)00316-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9230157%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference